Bone contains several growth factors, including bone morphogenetic proteins
(BMPs), transforming growth factor beta (TGF-beta), insulin-like growth fa
ctors I and II (IGF-I and IGF-II), platelet derived growth factor (PDGF) an
d basic and acidic fibroblast growth factor (bFGF and aFGF). Spatial and te
mporal variations in the expression and secretion of the various growth fac
tors have been demonstrated in osteoblastic cultures and in various experim
ental and clinical in vivo models including fracture healing in humans. Loc
al application of various growth factors influences proliferation, differen
tiation and protein synthesis in osteoblastic cultures and bone formation i
n different animal models, including experimental fractures and skeletal de
fects. The BMPs are the only growth factors known to provoke bone formation
heterotopically by making undifferentiated mesenchymal cells differentiate
into osteoblasts (osteoinduction). BMPs and other growth factors, soon to
become commercially available for clinical use, need a delivery system for
their sustained release, as the factors are otherwise rapidly absorbed. Som
e existing systems inhibit bone formation by inducing chronic inflammation
or physically by unresorbed carrier obstructing bone formation. New deliver
y systems are being investigated.